ASX - By Stock
|
PAB |
Re:
Ann: Appendix 4C - Quarterly - 30 June 2024
|
|
Dylboss
|
18 |
4.5K |
2 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
18
|
4.5K
|
2
|
|
ASX - By Stock
|
WGB |
Re:
Ann: December 2023 Investment Update
|
|
Dylboss
|
9 |
3.7K |
3 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
9
|
3.7K
|
3
|
|
ASX - By Stock
|
WGB |
Re:
Ann: December 2023 Investment Update
|
|
Dylboss
|
9 |
3.7K |
4 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
9
|
3.7K
|
4
|
|
ASX - By Stock
|
WGB |
Re:
Ann: December 2023 Investment Update
|
|
Dylboss
|
9 |
3.7K |
0 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
9
|
3.7K
|
0
|
|
ASX - By Stock
|
WGB |
Re:
Ann: December 2023 Investment Update
|
|
Dylboss
|
9 |
3.7K |
1 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
9
|
3.7K
|
1
|
|
ASX - By Stock
|
WGB |
Re:
Ann: December 2023 Investment Update
|
|
Dylboss
|
9 |
3.7K |
2 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
9
|
3.7K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Dylboss
|
10K |
5.0M |
19 |
20/10/22 |
20/10/22 |
ASX - By Stock
|
10K
|
5.0M
|
19
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Rett Syndrome NDA accepted for Priority Review by FDA
|
|
Dylboss
|
163 |
82K |
3 |
13/09/22 |
13/09/22 |
ASX - By Stock
|
163
|
82K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Dylboss
|
10K |
5.0M |
15 |
16/08/22 |
16/08/22 |
ASX - By Stock
|
10K
|
5.0M
|
15
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Dylboss
|
10K |
5.0M |
12 |
16/08/22 |
16/08/22 |
ASX - By Stock
|
10K
|
5.0M
|
12
|
|
ASX - By Stock
|
MGF |
Re:
Ann: MGF Fund Update - February 2021
|
|
Dylboss
|
521 |
189K |
0 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
521
|
189K
|
0
|
|
ASX - By Stock
|
MGF |
Re:
Ann: MGF Fund Update - February 2021
|
|
Dylboss
|
521 |
189K |
0 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
521
|
189K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Dylboss
|
10K |
5.0M |
1 |
30/05/22 |
30/05/22 |
ASX - By Stock
|
10K
|
5.0M
|
1
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Dylboss
|
33K |
16M |
0 |
05/05/22 |
05/05/22 |
Charts
|
33K
|
16M
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Best position ever .
|
|
Dylboss
|
73 |
34K |
2 |
20/04/22 |
20/04/22 |
ASX - By Stock
|
73
|
34K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
PHASE 2 START ANGELMAN, PMD, PITT HOPKINS
|
|
Dylboss
|
27 |
17K |
2 |
11/04/22 |
11/04/22 |
ASX - By Stock
|
27
|
17K
|
2
|
|
ASX - By Stock
|
MGF |
Re:
Ann: MGF Fund Update - February 2021
|
|
Dylboss
|
521 |
189K |
0 |
11/04/22 |
11/04/22 |
ASX - By Stock
|
521
|
189K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Dylboss
|
10K |
5.0M |
8 |
28/03/22 |
28/03/22 |
ASX - By Stock
|
10K
|
5.0M
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Dylboss
|
10K |
5.0M |
3 |
21/03/22 |
21/03/22 |
ASX - By Stock
|
10K
|
5.0M
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Dylboss
|
10K |
5.0M |
12 |
17/03/22 |
17/03/22 |
ASX - By Stock
|
10K
|
5.0M
|
12
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Dylboss
|
10K |
5.0M |
5 |
17/03/22 |
17/03/22 |
ASX - By Stock
|
10K
|
5.0M
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Dylboss
|
10K |
5.0M |
3 |
14/03/22 |
14/03/22 |
ASX - By Stock
|
10K
|
5.0M
|
3
|
|
ASX - By Stock
|
MGF |
Re:
Ann: MGF Fund Update - February 2021
|
|
Dylboss
|
521 |
189K |
0 |
08/03/22 |
08/03/22 |
ASX - By Stock
|
521
|
189K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Ann: FDA approval for Angelman IND and Phase 2 trial
|
|
Dylboss
|
11 |
6.5K |
7 |
25/02/22 |
25/02/22 |
ASX - By Stock
|
11
|
6.5K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Dylboss
|
10K |
5.0M |
9 |
23/02/22 |
23/02/22 |
ASX - By Stock
|
10K
|
5.0M
|
9
|
|
ASX - By Stock
|
NEU |
Re:
ACAD presentation
|
|
Dylboss
|
36 |
21K |
1 |
18/02/22 |
18/02/22 |
ASX - By Stock
|
36
|
21K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Dylboss
|
10K |
5.0M |
0 |
15/02/22 |
15/02/22 |
ASX - By Stock
|
10K
|
5.0M
|
0
|
|
ASX - By Stock
|
MGF |
Re:
Ann: MGF Fund Update - February 2021
|
|
Dylboss
|
521 |
189K |
1 |
14/02/22 |
14/02/22 |
ASX - By Stock
|
521
|
189K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Dylboss
|
10K |
5.0M |
8 |
14/02/22 |
14/02/22 |
ASX - By Stock
|
10K
|
5.0M
|
8
|
|
ASX - By Stock
|
PAB |
Re:
Ann: PAT-DX1 engineering update
|
|
Dylboss
|
176 |
59K |
2 |
14/02/22 |
14/02/22 |
ASX - By Stock
|
176
|
59K
|
2
|
|
ASX - By Stock
|
PAB |
Re:
Ann: PAT-DX1 engineering update
|
|
Dylboss
|
176 |
59K |
1 |
14/02/22 |
14/02/22 |
ASX - By Stock
|
176
|
59K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Dylboss
|
10K |
5.0M |
4 |
14/02/22 |
14/02/22 |
ASX - By Stock
|
10K
|
5.0M
|
4
|
|
ASX - By Stock
|
NEU |
Re:
ANAVEX MEETS ENDPOINTS PHASE2 RETT
|
|
Dylboss
|
166 |
78K |
2 |
09/02/22 |
09/02/22 |
ASX - By Stock
|
166
|
78K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
ANAVEX MEETS ENDPOINTS PHASE2 RETT
|
|
Dylboss
|
166 |
78K |
4 |
09/02/22 |
09/02/22 |
ASX - By Stock
|
166
|
78K
|
4
|
|
ASX - By Stock
|
PYR |
Re:
Something fishy with payright
|
|
Dylboss
|
7 |
3.8K |
1 |
08/02/22 |
08/02/22 |
ASX - By Stock
|
7
|
3.8K
|
1
|
|
ASX - By Stock
|
MGF |
Re:
Ann: MGF Fund Update - February 2021
|
|
Dylboss
|
521 |
189K |
1 |
08/02/22 |
08/02/22 |
ASX - By Stock
|
521
|
189K
|
1
|
|
ASX - By Stock
|
MGF |
Re:
Ann: MGF Fund Update - February 2021
|
|
Dylboss
|
521 |
189K |
4 |
07/02/22 |
07/02/22 |
ASX - By Stock
|
521
|
189K
|
4
|
|
ASX - By Stock
|
MFG |
Re:
Ann: Hamish Douglass - Medical Leave of Absence
|
|
Dylboss
|
186 |
90K |
3 |
07/02/22 |
07/02/22 |
ASX - By Stock
|
186
|
90K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Notification regarding unquoted securities - NEU
|
|
Dylboss
|
16 |
5.8K |
3 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
16
|
5.8K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Q4 2021 quarterly activity and cash flow report
|
|
Dylboss
|
42 |
18K |
7 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
42
|
18K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Q4 2021 quarterly activity and cash flow report
|
|
Dylboss
|
42 |
18K |
14 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
42
|
18K
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Dylboss
|
10K |
5.0M |
11 |
27/01/22 |
27/01/22 |
ASX - By Stock
|
10K
|
5.0M
|
11
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Dylboss
|
10K |
5.0M |
3 |
24/01/22 |
24/01/22 |
ASX - By Stock
|
10K
|
5.0M
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Dylboss
|
10K |
5.0M |
2 |
20/01/22 |
20/01/22 |
ASX - By Stock
|
10K
|
5.0M
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Dylboss
|
10K |
5.0M |
9 |
18/01/22 |
18/01/22 |
ASX - By Stock
|
10K
|
5.0M
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Dylboss
|
10K |
5.0M |
0 |
17/12/21 |
17/12/21 |
ASX - By Stock
|
10K
|
5.0M
|
0
|
|
ASX - By Stock
|
MFG |
Re:
The Horse has Bolted
|
|
Dylboss
|
64 |
23K |
3 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
64
|
23K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Takeover discussion
|
|
Dylboss
|
39 |
17K |
3 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
39
|
17K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Dylboss
|
10K |
5.0M |
8 |
15/12/21 |
15/12/21 |
ASX - By Stock
|
10K
|
5.0M
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
Dylboss
|
1.2K |
657K |
7 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
1.2K
|
657K
|
7
|
|